We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


18 Nov 2019 - 21 Nov 2019
02 Dec 2019 - 06 Dec 2019

Global In Vitro Diagnostics Market to Reach USD 90 Billion by 2025

By Labmedica International staff writers
Posted on 07 Feb 2019
Print article
Image: The global in vitro diagnostics market is projected to grow between 2017 and 2025 to reach almost USD 90 million by the end of 2025 (Photo courtesy of iStock).
Image: The global in vitro diagnostics market is projected to grow between 2017 and 2025 to reach almost USD 90 million by the end of 2025 (Photo courtesy of iStock).
The global in vitro diagnostics market was valued at USD 55.00 billion in 2016 and is projected to grow at a healthy CAGR of 5.60% between 2017 and 2025 to reach USD 89.8 billion by the end of 2025. The market growth will be driven by the rising prevalence of chronic diseases worldwide, an increase in the number of public and private diagnostic centers due to growing awareness of various diseases among the people, and an increasingly health conscious population who prefer early treatment. Additionally, the aggressive growth in the health sector and rapid technological advancements are helping to create better and more efficient products, thereby further aiding the market growth.

These are the latest findings of Transparency Market Research, (Albany, NY, USA), a global market intelligence company providing business information reports and services.

Increasing incidences of chronic diseases such as cancer, tuberculosis, diabetes, and cardiovascular diseases are likely to drive the growth of the global in vitro diagnostics market over the coming years. Additionally, a surge in the number of patients suffering from infectious diseases, such as sexually transmitted diseases (STDs), respiratory, and gastrointestinal, are expected to further boost the demand in the market. A sharp increase in cardiovascular diseases and diabetes, particularly in the developed countries, has helped the in vitro diagnostic market grow at a stupendous pace. Moreover, an increase in the geriatric population is also fueling market demand as the elderly people are more vulnerable to diseases due to their low immunity, thereby boosting the overall healthcare industry and resulting in the huge growth of the vitro diagnostic market.

The healthcare industry has been witnessing tremendous development and is expected to continue growing during the forecasts period on the back of the advent of personalized medicines and rise in the uptake of automated instruments. Earlier, in vitro diagnostics used to be performed only in labs, but can now be quickly and accurately carried out at home without the presence of any skilled professionals. One can test for pregnancy, blood glucose levels and even diseases such as HIV at home without visiting a diagnostic center, resulting in reduced hospital bills and increasing convenience. Such devices have gained immense popularity among the people due to their user-friendly nature, thus further boosting the growth of the in vitro diagnostics market. However, frequent regulatory changes and the lack of favorable reimbursement facilities for in vitro diagnostic are likely to hamper the market growth.

Currently, the global in vitro diagnostics market is highly competitive with a large number of players operating worldwide. The increasing emphasis of the key players on research and development, coupled with the introduction of new technology, is expected to support the market growth over the next few years. Additionally, increasing mergers and acquisition are likely to help the leading players maintain their position and increase market penetration in the coming years.

Related Links:
Transparency Market Research

Print article


Molecular Diagnostics

view channel
Image: The fluorescence fingerprinting device can test saliva for the presence of the synthetic cannabinoid receptor agonist “spice” in about five minutes (Photo courtesy of University of Bath)

Rapid Fluorescence Fingerprinting Assay for Identification of Synthetic Cannabinoid Receptor Agonists

A team of British researchers developed a rapid real-time, point-of-care test for the identification of synthetic cannabinoid receptor agonists (SCRAs), a class of illegal drugs known colloquilly as “Spice” or “K2”.... Read more


view channel
Image: A blood film showing neutrophils and lymphocytes and other white and red blood cells, and a platelet (Photo courtesy of University of Minnesota).

Hematological Ratios Associated with Mortality in Pediatric Trauma Patients

Trauma-related injury as a potential cause of death affects millions of people worldwide, especially in less developed countries and furthermore, it is the leading cause of mortality in pediatric trauma patients.... Read more
Copyright © 2000-2019 Globetech Media. All rights reserved.